Latest Research on Hospital Gowns Market Size, Share and Forecast

 Market Highlights:

According to MRFR analysis, the Global Hospital Gowns are expected to register a CAGR of 6.6% during the forecast period of 2020 to 2027 and reach USD 5.02 Billion by 2027.

A hospital gown is usually a short collarless gown that ties in the back, worn by patients being examined or treated in a doctor’s office, clinic, or hospital.

The growth of the hospital gowns market can be attributed to the growing need for personal protective equipment, due to the outbreak of COVID 19 globally and a rise in hospital-acquired infections.

Moreover, the increasing usage of disposable lab coats and hospital gowns for patients and increasing safety measures & hygiene by the government for the safety of patients& healthcare professionals, are expected to fuel the market growth during the forecast period.

Surgical and disposable gowns are vital for protecting healthcare staff performing procedures on patients infected with the disease. Re-usage of hospital gowns and the availability of fake products are expected to restrain the growth of the global hospital gowns market. The Center for Disease and Prevention (CDC) issues recommendations for when and what personal protective equipment should be used to prevent exposure to infectious diseases.

Several market players such as Medline Industries, 3M, and Priontex among others are currently dominating the global hospital gowns market.

Regional Analysis:

The market has been divided by region into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The hospital gowns market in Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. North America influences the global market for the hospital gowns market. The European hospital gowns market has been categorized as Western Europe and Eastern Europe. The Western Europe market has further been divided as Germany, France, Italy, Spain, the UK, and the rest of Western Europe. The global market of hospital gowns in Asia- Pacific has been segmented into Japan, China, India, Australia, South Korea, and Rest of Asia- Pacific. The Middle East and Africa hospital gowns market have been bifurcated as the Middle East and Africa.

Access Report Details @ https://www.marketresearchfuture.com/reports/hospital-gowns-market-9616  

Segmentation:

The global hospital gowns market has been segmented based on type, risk type, and usability.

Based on type, the global hospital gowns market has been segmented into surgical, non-surgical, and patient gowns. The patient gowns segment is anticipated to be the fastest-growing segment during the forecast period due to the rise in the number of COVID 19 patients, surgeries, and growing cases of hospital-acquired infections.

On the basis of risk type, the market has been segmented into minimal risk, low risk, moderate risk, and high risk. Minimal risk hospital gowns are expected to register the highest CAGR during the forecast period owing to large applications of minimal gowns, used in the basic care unit, standard medical unit, and standard isolation as well as for research and academic purposes.

Based on the usability the market has been segmented into disposable and reusable gowns. The disposable gowns segment is estimated to adjure the leading share in the hospital gowns market throughout the forecast period due to cost-effectiveness and safety assurance of disposable gowns.

Key Players

Some of the key players in the global hospital gowns market are Medline Industries Inc. (US), Standard Textile Co. Inc. (US), Angelica Corporation (US), AmeriPride Services Inc. (US), Cardinal Health (US), 3M (US), Atlas Infiniti (India), Bellcross Industries Pvt. Ltd. (India), Priontex (South Africa), Sara Healthcare (India)

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/9616 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Veterinary Imaging Market 2021 Revenue Analysis, Growth opportunities, Company Profiles,Key Trends, Size, Share and Research Depth Study 2027

 Global Veterinary Imaging Market  - Overview

The global veterinary imaging market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Veterinary deals with diagnosis and treatment of diseases in animals. Veterinary imaging devices are useful in diagnosis and treatment of diseases in animals. These devices also gives clear understanding of disease or injury that helps veterinarian for treatment of animal. Increasing awareness about animal healthcare and improvement of animal life are key factors for the growth of the market. Disease pattern in animals are continuously changing and becoming more challenging for veterinarians to diagnose these diseases. Veterinary imaging devices gives them in accurate diagnosis and further treatment. Increasing pet adoption is another major factor for the growth of the market. Increasing number of veterinarians, veterinary clinics and growing veterinary healthcare infrastructure are driving the growth for the market. Cattle are very important part of farming that have economic importance because they provides many products like milk, meat and leather. Farmers are becoming more aware about the health of their cattle which is good sign for the growth of the market. About 75% of veterinarians are working in private hospitals or pet clinics and these hospitals or clinics are spending money in advancement of technology to provide better facilities. Veterinary imaging devices manufacturers are spending money to develop innovative and usable product for the market. However there are some factors are inhibiting the growth of the market such as high cost of devices that small clinics cannot afford, lack of knowledge about new technology or products, availability of products, access to veterinary healthcare facilities, lack of skilled veterinary professionals etc.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2919

Top Companies: 

Atlantis Worldwide (US), Canon Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Fujifilm Holdings Corporation (Japan), GE Healthcare (US), Hitachi, Ltd (Japan), Medical Imaging / IMCO, Inc. (US), Sectra (Sweden), Siemens AG (Germany), Toshiba Medical Systems Corporation (Japan) are some of the prominent players at the forefront of competition in the Global Veterinary Imaging Market and are profiled in MRFR Analysis. 

Report Details @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919

Global Veterinary Imaging Market  - Competitive Analysis

Characterized by the presence of several well-established and small players, the global market of veterinary imaging appears to be highly competitive and fragmented. Major market players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The Market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers. Therefore, key players ensure that their portfolio includes products both for treating sick animals and for preventing disease occurrence.

December, 2015 - Fujifilm and Anicom Holdings, Inc. entered into partnership and established joint venture for developing and providing cutting-edge veterinary technologies and services with focus on regenerative medicine. According to company reports, it had developed advanced veterinary medicine by combining Fujifilm's advanced production engineering and quality control technology nurtured in its photographic film business as well as diagnostic imaging technology, blood's chemical composition analysis technology and regenerative medical technology, with Anicom's veterinary hospital network, electronic medical record system and extensive animal treatment data. Moreover, the company had conducted science-based clinical research such as regenerative medicine including cell therapies.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Global Veterinary Imaging Market - Regional Analysis

Depending on geographic region, veterinary imaging market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, North America holds be the largest market for veterinary imaging due to increasing awareness about animal healthcare and increasing investment in healthcare domain. Moreover the European market is also growing and second largest market for Veterinary Imaging. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the Veterinary Imaging during the forecasted period. Whereas, The Middle East & Africa have the least market share. Additionally, factors such as lack of awareness, low healthcare expenditures will restrain the market during the corresponding period.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

 

Allergy Immunotherapy Market 2021- Emerging Trend, Demand, Opportunities, Challenges, Growth Opportunities, Key Driven Factors

Allergy Immunotherapy Market

Allergy Immunotherapy Market Insights:

Market Research Future (MRFR)’s latest report reveals that the global allergy immunotherapy market is set to exhibit a steep rise in growth registering a CAGR of 10.85% during the forecast period 2017 to 2023. The market has been estimated to reach a valuation of USD 4,324.7 Mn by the end of 2023. The widespread prevalence of allergies has fueled demand in the allergy immunotherapy market. The trend is anticipated to perpetuate over the next couple of years. According to a report published by the World Health Organization (WHO), approximately 10-40% of the population was suffering from allergy in 2013.

Request Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/1517 

The increasing patient pool coupled with the availability of advanced allergy treatment procedures has augured well for the players of the allergy immunotherapy market. The market is expected to remain highly lucrative in the foreseeable future, and the increased investments in clinical trials and research & development activities are set to catapult the market on an upward trajectory. 

The developing healthcare sector in emerging markets in Latin America, Asia, etc. are anticipated to steer the growth of the allergy immunotherapy market. Other favorable factors encouraging the growth of the market include increasing awareness of the treatment, technological advancement, growth strategies of major players, etc.

Allergy Immunotherapy Market Segmentation:

By allergy type, the global allergy immunotherapy market has been segmented into allergic rhinitis, allergic asthma, peanut allergy, cat allergy, and other allergies. The allergic rhinitis segment currently accounts for a dominant share of the market. Meanwhile, the peanut allergy segment is estimated to register a CAGR of 11.3%.

By treatment, the allergy immunotherapy market is segmented into Subcutaneous Immunotherapy (SCIT), sublingual immunotherapy, and Specific Immunotherapy (SIT). The Subcutaneous Immunotherapy (SCIT) segment holds the largest share of the market and is projected to reach a valuation of USD 2,089.2 by 2023.

Allergy Immunotherapy Market Regional Analysis:

By region, the global allergy immunotherapy market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Europe accounts for the maximum share of the market and is expected to retain a significant share of the market towards the end of the assessment period. Led by Western Europe, the factors favoring the growth of the regional market are increasing patient pool, rising healthcare expenditure, etc.

Americas market is estimated to reach a valuation of USD 1,409.6 Mn by 2023. The growth is attributable to the increasing awareness regarding treatment of allergies and high prevalence of allergic rhinitis & skin allergy. 

Asia Pacific is projected to register a CAGR of 11.32% during the forecast period. Meanwhile, the U.A.E. currently holds 53.5% share of the Middle East & Africa market and resonates strong opportunities for growth.

Allergy Immunotherapy Market Competitive Dashboard:

Some of the key players profiled in the report are ALK Abello A/S (Denmark), DBV Technologies (France), Stallergenes Greer (UK), HAL Allergy Group (Netherlands), Allergy Therapeutics (UK), Merck KGaA (Allergopharma) (Germany), and Circassia (UK) among others.

Industry Developments:

In August 2018, Arrayit Corporation, life sciences, and personalized medicine company announced its partnership with multiple providers of allergen immunotherapy products for allergy testing to treat patients with allergy and asthma.

In August 2018, Astria Sunnyside Hospital announced the availability of an allergy testing and treatment program. Allergy treatment options being offered at the hospital include sublingual immunotherapy and regular allergy shots.

Read Complete Report with  Toc @ https://www.marketresearchfuture.com/reports/allergy-immunotherapy-market-1517 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

Elastography Imaging Market Insights, Trends, Opportunity & Forecast to 2027

 The global elastography imaging market is growing pervasively, witnessing the rising cancer cases worldwide. Elastography imaging technology has become increasingly popular in the diagnostic data during surgery. The technique is extensively used during the radiology, general imaging, cardiology, cancer, obstetrics, gynecology, urology, vascular, and orthopedic & musculoskeletal applications. 

Get free Sample @ https://www.marketresearchfuture.com/sample_request/8070 

Market Research Future (MRFR), in its recent elastography imaging market insights, asserts that the global elastography imaging market valuation had reached USD 2,538.2 MN in 2018, which is estimated to appreciate further at 11.1% CAGR during the forecast period (2019 to 2025). The growing prevalence of life-threatening diseases and increasing demand for minimally invasive procedures to diagnose and treat different chronic diseases, alongside the elastography imaging market trends, act as major driving forces for the market growth. 

Besides, the increasing launches of innovative systems with easy to use technologies are helping the market to grow freely. Growing awareness about the benefits of elastography imaging technique in cancer detection, impact the growth of the market positively. Conversely, high costs of elastography imaging systems and the requirement of high initial investments are the major factors projected to impede market growth during the forecast period. Nevertheless, changes in regulatory policies and rising demand for effective therapies to treat complicated disorders would support the market growth throughout the analyzed period.

 

Global Elastography Imaging Market   - Segmentations

The report has been segmented into four main dynamics.

By Modality : Ultrasound, Magnetic Resonance Elastography, and others. 

By Application : Radiology/General Imaging, Cardiology, Obstetrics/Gynecology, Urology, Vascular, Orthopedic & Musculoskeletal Applications, and others. 

By End User : Hospitals & Ambulatory Surgical Centers, Diagnostic Centers, Research Laboratories, and others. 

By Regions : Americas, Europe, APAC, Middle East & Africa, and Rest-of-the-World.

 

Global Elastography Imaging Market - Geographical Analysis

North America dominates the global elastography imaging market. The largest market share attributes to the rising numbers of cancer patients and the high adoption of new technology in the region.  Besides, the presence of major market players and the increasing usages of elastography imaging techniques for the detection of cancer are spurring market growth. Also, the high healthcare expenses and technological advances in elastography imaging drive the regional market growth. 

Additional factors such as the increasing R&D expenses, the increase in the insurance coverage, and improving reimbursement scenario in the US & Canada fuel the growth of the regional market. The North American elastography imaging market is expected to retain its dominance over the global market throughout the assessment period.

Europe holds the second-largest share in the global elastography imaging market. The market is majorly driven by the considerable growth in the occurrences of cancer and the increasing support & funding from regulatory authorities to control the rising prevalence of cancer. Moreover, factors such as the presence of well-established healthcare systems and the rising per capita healthcare spending, drive the regional market growth. Also, augmenting demand for innovative diagnosis techniques has been increasing the elastography imaging market size.

The elastography imaging market in the Asia Pacific region is growing briskly. The market is predominantly led by raising awareness about the advantages of elastography imaging systems in the detection & treatment of cancer. Additionally, the increasing number of patients with chronic diseases and government initiatives for healthcare reforms push the market growth excellently. Furthermore, factors such as the increasing healthcare expenses, resurging economy in the region, and spreading awareness about elastography techniques, influence the growth of the regional market. 

 

Global Elastography Imaging Market   - Competitive Landscape

Highly competitive, the elastography imaging market appears fragmented, with many well-established players forming a competitive landscape. To gain a larger competitive share, market players adopt strategic approaches such as mergers & acquisitions, product & technology launch, expansion, and collaboration. Players make substantial investments to drive the R&D required for innovation and product launch. They also invest in increasing their global footprint and acquiring promising companies from emerging markets. 

 Major Players:

Players leading the global elastography imaging market include Canon Medical Systems Corporation, Esaote, Fujifilm Holdings Corporation, General Electric Company, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Ltd., Resoundant Inc., Samsung Electronics (Samsung Medison), Siemens AG, and Supersonic Imagine, among others. 

Industry/Innovation/Related News:

April 30, 2020 ---- American Association for Cancer Research published a study a recent Cancer Research in which the diagnostic accuracy of quantitative micro-elastography for margin assessment in breast-conserving surgery has been evaluated. The study reveals that imaging plus elastography enhances surgical margin assessment in breast cancer. Findings from the study - Quantitative microelastography demonstrated increased sensitivity, specificity, and accuracy in detecting positive surgical margins in combination with optical coherence tomography versus optical coherence tomography alone in women who received breast-conserving surgery.

The ideal scenario to perform the imaging in the surgical cavity is immediately after the specimen has been removed. This would give surgeons a direct indication of whether any tumor had been missed. The next goal of the research team is to develop a handheld quantitative microelastography probe to enable intraoperative imaging.

Read More @ https://www.marketresearchfuture.com/reports/elastography-imaging-market-8070 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Animal Genetics Market Size, Share, Global Trends, Revenue Analysis, Business Insights, Developments and Opportunity Assessment by 2027

 Market Overview

Animal genetics can be defined as the branch of science, which involves the study of gene variation and inheritance in wild and domestic animals. It is extensively used for genetic trait testing and DNA testing. The animal genetics market is predicted to propel owing to the ingesting of animal proteins and surging urban population across the globe, which has resulted in increased demand for meat products. The global animal genetics market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 8.4% during the forecast period (2018-2023).

The animal genetics market has witnessed a tectonic surge over the past few years due to increased consumption of animal proteins and rapid growth in urban population. The improvement of animal welfare, along with the advancement of genetic technologies, are driving the market globally. The market will experience tremendous growth due to increased adoption of genetic services in order to prevent business loss and genetic diseases. Significant investments in R&D activities and expansions by industry players will influence the market growth in the coming years.

On the flipside, the lack of skilled professionals, strict regulatory framework associated with genetic engineering, and the high cost of animal testing are predicted to slow down the market growth in the years to come.

Global Animal Genetics Market: Segmental Analysis

Based on animal genetic products, the market is segmented into live animals and genetic materials. The soaring demand for animal products like mutton, pork, coupled with rapid urbanization is estimated to propel the market growth in the segment. Rising adoption of artificial insemination in sheep, cattle, goats, and pigs will further enhance the market growth in the segment.

The animal genetics market by services is segmented into DNA typing, genetic disease tests, gene trait tests, and others. Soaring awareness of animal health, coupled with the surging number of genomic disease testing in order to prevent the loss of large-scale production will offer the market lucrative growth opportunities. The rising number of several animal genetic diseases and increased incidences of the zoonotic disease will drive the demand for genetic trait tests.

The end users segment comprises diagnostic centers, veterinary hospitals & clinics, research centers and institutes, and others.

Regional Frontiers

Geographically, the animal genetics market spans across America, Asia Pacific, Europe, and the Middle East & Africa.

Considering the global scenario, the animal genetics market was dominated by America in 2017 and is estimated to retain its pole position in the years to come. The growth is credited to the increased demand for animal products like mutton and pork. Rapid urbanization in the region has further encouraged the market growth in the region. Surging adoption of artificial insemination in sheep, cattle, goats, and pigs are further estimated to influence the market in America. In this region, North America commands the largest share due to surging adoption of pet ownership, adoption of the latest diagnostic technologies, and advanced animal healthcare base. Surging demand for safe livestock production, coupled with increased investment in R&D by the key players are likely to propel the market growth in the coming years.

Europe acquired the second position in the global market due to soaring awareness regarding animal health, an increasing number of animal genetic diseases, and surging incidences of zoonotic diseases. Mounting demand for well-bred animals with good quantitative genetic characteristics, along with the soaring demand for poultry and livestock products will propel the market in Europe.

Meanwhile, the Asia Pacific will register the fastest growth due to growth in livestock population, coupled with the advancements made in genetic testing tools and DNA typing. This has further resulted in increased demand for genetic trait tests and diagnostic testing. Moreover, the development of the healthcare sector in countries like India and China will make this market highly promising.

Competitive Dashboard

The top players operating in the animal genetics market include Genus (UK), Neogen Corporation (US), EW Group (Germany), URUS (US), CRV Holding B.V. (The Netherland), Groupe Grimaud (France), Zoetis (US), Topigs Norsvin (Netherlands), Animal Genetics (US), Envigo (US) Hendrix Genetics BV (The Netherland), vetGen (US), Alta Genetics (US), and others.

REad More @ https://www.marketresearchfuture.com/reports/animal-genetics-market-7004 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

Biosimilars Market Share, Industry Size, Growth Analysis, Competitive Landscape, Segmentation, Future Prospects and Regional Forecast 2027

 Market Synopsis

Market Research Future (MRFR) postulates that the biosimilars market is predicted to garner USD 3.35 billion, grabbing a CAGR of 26% throughout the forecast period (2017-2023). The augmenting incidences of several chronic diseases are estimated to favor the market growth. Biosimilars are referred to as a biological medical product which are identical copies of the original medical product. They are generally derived from a plant, bacteria, yeast, and other several processes. Biosimilars are neither generics nor treated like generic drugs. Also acknowledged as bio-pharmaceuticals, biosimilars differ from generics in the manufacturing process. They are produced by two main processes, recombinant DNA technology and controlled gene expression.

Market Potential and Pitfalls

With the augmenting incidences of several chronic diseases, growing demand for cheap medical products, and strategic collaborations leading to clinical trials and enhanced productivity, the global biosimilars market is estimated to flourish throughout the appraisal period. Biosimilars are extensively used in the treatment and prevention of chronic diseases like cancer, diabetes, autoimmune disease, cardiovascular diseases (CVDs), kidney failure, rheumatoid arthritis, hematological disease, hormone growth deficiency, and infectious disease. This is likely to create momentum to the market growth during the estimated period. Also, with the growth in the geriatric population, the demand for biosimilars is expected to trigger.

Biosimilars are constantly gaining prominence over other conventional biologics due to lesser cost as compared to the parent biological drugs. Moreover, different private and government bodies are promoting the use of biosimilars over synthetic drugs and conventional biologics, which is further propelling the growth of the market across the globe. Also, with the rapid growth in the pharmaceutical sector combined with the high cost of existing biological drugs, the market is anticipated to boom. 

On the contrary, physician skepticism coupled with the lack of awareness regarding biosimilars is some of the top barriers likely to vitiate the market growth in the coming years. Additionally, complexity and high manufacturing cost can act as roadblocks to the mainstream production of biosimilars. Despite such hiccups, discounted prices of biosimilars will impact the overall biosimilar sales, as patients are the key beneficiaries.

Global Biosimilars Market: Segmental Analysis

The global biosimilars market has been segmented on the basis of product, application, and manufacturing.

By mode of product, the global biosimilars market has been segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and others. Among these, the recombinant glycosylated proteins segment is anticipated to occupy the largest share and is likely to retain its dominance. The growth is credited to the wide therapeutic area of such proteins coupled with the presence biosimilar version of monoclonal antibodies at much lower rates. 

By mode of application, the global biosimilars market has been segmented into oncology, immune diseases, blood-related disorders, and others.

By mode of manufacturing, the global biosimilars market has been segmented into contract manufacturing and in-house manufacturing. Among these, the in-house manufacturing is presumed to occupy the largest share owing to the rising demand for cost-effective biosimilar products due to the augmenting incidences of several chronic diseases.

Regional Insights

Geographically, the biosimilars market span across regions namely, Europe, Asia Pacific, North America, and the Middle East & Africa.

Among all the regions, the European region is likely to dominate the global biosimilars market and is estimated to retain its dominance in the coming years. The growth is credited to the rising prevalence of diseases coupled with the growth in the geriatric population in this region. Moreover, advanced medical research and technological advancements are further triggering the demand for biosimilars in this region. The growth in the regional market is likely to be stimulated by patent expiry of biologic products combined with the launch of new biosimilars and the advent of new market participants.

The North American region is predicted to occupy the second largest share in the global market owing to technological advancements and extensive medical research. The market is mainly driven by the presence of large research labs such as Amgen, Sandoz, Teva Pharmaceutical, and others.

The Asia Pacific region is anticipated to emerge as the fastest-growing region owing to the immense economic development coupled with the booming biotechnology companies in this region. The country-specific markets in this region generating maximum revenue are India, Australia, South Korea, Japan, and China.

Industry Updates

February 19, 2019: Sandoz, a developer of biosimilar has recently announced the launch of their biosimilar adalimumab, Hyrimoz, in Spain. This biosimilar, referencing Humira, was authorized in the European Union for sale in July 2018. It has been approved for indications of reference adalimumab and is available in 40 mg doses for subcutaneous injection in pre-filled pen or a syringe form.

Competitive Dashboard

The prominent players operating the global biosimilars market are Biocon Ltd. (India), Eli Lilly (U.S.), Novartis (Switzerland), Celltrion Inc. (South Korea), Dr. Reddy’s Laboratories Ltd. (India), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Sandoz International GmbH (Germany), Astra Zeneca (U.K.), Amgen Inc. (U.S.), Samsung Bioepis (South Korea), F. Hoffmann-La Roche Ltd. (Switzerland), and Accord Healthcare (U.K.).

Read Complete Report @ https://www.marketresearchfuture.com/reports/biosimilars-market-1329 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Venous Blood Collection Devices Market 2027– Global Industry Size, share, Business Insights

 Venous blood collection devices are used to collect sample from patients. Venous blood collection devices include needles, holders, collection tubes, and other devices. As per an in-depth research study published by Market Research Future (MRFR), the global venous blood collection devices market is estimated to post a CAGR of 9.3% over the forecast period of 2017-2023. 

Substantial improvements made by medical device manufacturers towards safer blood collection. Advances in safety features and greater emphasis on the prevention of injury and reduction of bloodborne pathogen exposure fuel the growth of the global venous blood collection devices market. Moreover, medical device manufacturers are endeavoring towards product improvement and are diversifying their product portfolios as a growth strategy which also acts as a plus for the growth of the market. Crucial advancements include the introduction of plastic tubes, protective sliding needle shields, automatically retracting lancets, and winged-needle blood collection sets. 

Chronic diseases are spreading at a brisk pace which has exerted massive burden on the healthcare sector. Screening for diseases induces high demand for diagnostic services which, in turn, triggers growth within the global venous blood collection devices market. Other factors which can accelerate the market growth include surging health & wellness awareness among the global populace, the rise in disposable income, and high healthcare expenditure. 

On the flip side, venous blood collection devices are associated with the risk of needlestick injuries, contamination risks which can restrict the market growth. Additionally, pricing pressure on medical device manufacturers and substandard products from local medical device manufacturers can also undermine the growth of the market. 

Segmentation

The global venous blood collection devices market has been segmented based on type, material, application, and end user.

By type, the global venous blood collection devices market has been segmented into blood collection tubes, needles, microfluidic system, vacuum blood collection system, micro-container tubes, micro-hematocrit tubes, warming devices, and others. Other venous blood collection devices include venous cannula and blood bags. The blood collection tube segment has been further segmented into plasma separation tube, heparin tube, serum separating tube, EDTA tube, and others.

By material, the global blood collection devices market has been segmented into plastic, glass, stainless steel, ceramic, and others.

By application, the global venous blood collection devices market has been segmented into vein blood gas sampling and intraoperative blood salvage. The vein blood gas sampling segment has been further segmented into diagnosis of disease and acid-base status monitoring.

By end user, the global venous blood collection devices market has been segmented into hospitals and clinics, blood donation centers, the point of care, diagnostic centers, and others.

Regional Analysis

By region, the global venous blood collection devices market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). 

The Americas is spearheading the global venous blood collection devices market. Rapid adoption of new surgical techniques and instruments within the healthcare sector in the region are substantiating the growth of the market. High demand for screening services coupled with high healthcare expenditure is driving the market growth. Moreover, greater awareness among consumers and favorable reimbursement landscape support the growth of the market. 

Europe ranks second in the global venous blood collection devices market. High-income population and deep healthcare penetration in the region are favoring the growth of the market in Europe.

The expanding healthcare sector in the developing countries such as China and India generate high demand for venous blood collection devices in APAC. The rise in the geriatric population, the prevalence of chronic diseases which require screening services and increased demand for advanced blood sampling techniques are propelling the growth of the APAC venous blood collection devices market.

The MEA market is estimated to expand at a steady pace over the forecast period. Accelerated development of the healthcare sector and awareness programs launched by the government towards safe blood transfusion procedures are triggering growth within the MEA market. 

Competitive Landscape

The key players in the global venous blood collection devices market include SanLI (Myanmar.), KHB (U.S.), Allegro Medical Supplies Inc. (Scrip Products Corporation) (U.S.), Bio-Rad Laboratories, Inc. (U.S), Kabe Labortechnik GmbH (Germany), NIPRO Medical Corporation (Japan), Qiagen NV (Netherlands), Sarstedt AG & Co (U.S.), Fisher Scientific (Thermo Fisher Scientific Inc.) (U.S.), Greiner Bio One International GmbH (Greiner Group) (Austria), Becton, Dickinson and Company (U.S), Terumo Medical Corporation (Japan), Medtronic Plc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Radiometer Medical ApS (Danaher Corporation/ Danrad ApS) (Denmark), Improve Medical Technology Co. Ltd. (U.S.), Sekisui Chemical Co., Ltd. (Japan), Hongyu Medical (China), Narang Medical (India), Vital Diagnostice (ELITech Group) (U.S.), Zhejiang Gongdong Medical Technology Co., Ltd. (China), CDRICH (China), Biosigma (U.S.), Soya Green Tec Co., Ltd. (South Korea), and F.L. Medical (Italy). 

Industry Updates

March 2019- Becton Dickinson & Co., a medical technology company, announced that the US FDA had granted pre-market approval for its new Venovo stent. The new device is ideally suited for the treatment of iliofemoral occlusive disease and specially designed to address the challenges associated with venous lesions. 

Read More @ https://www.marketresearchfuture.com/reports/venous-blood-collection-devices-market-5761

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Diabetic Retinopathy Market Trends, Global Demand to Forecast

 Diabetic Retinopathy Market Driven by Growing Prevalence of Diabetes 

Growing Prevalence of Diabetes to Drive Diabetic Retinopathy Market 

The global diabetic retinopathy market is expected to exhibit a strong 11.9% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The global diabetic retinopathy market was valued at USD 1.3 trillion in 2018.

Diabetic retinopathy is diabetes-associated damage caused to the eyes. Diabetes can have an adverse impact on eye health, as high sugar volume in the blood can result in damage to the blood vessels, especially weaker and thinner blood vessels. As the blood vessels in the eyes are usually thin and thus weak, diabetes can heavily affect these blood vessels and cause them to be blocked or ruptured. This causes a variety of conditions known by the umbrella term of diabetic retinopathy. This can also result in the growth of new, abnormal blood vessels on the retina, leading to further complications. The symptoms of diabetic retinopathy include vision loss, impaired color vision, blurred vision, floaters, or dark or empty areas in the vision. Complications associated with diabetic retinopathy include blindness, glaucoma, retinal detachment, and vitreous hemorrhage. The high severity of these complications has resulted in diabetic retinopathy being taken seriously by patients suffering from or at risk of contracting diabetes. 

The growing prevalence of diabetes is likely to be a major driver for the global diabetic retinopathy market over the forecast period. Due to the increasing prevalence of a sedentary lifestyle and the increasing consumption of fast food and junk food, the prevalence of diabetes has grown rapidly in the last few decades. Developing regions such as Asia Pacific have become a major center for the growth in prevalence of diabetes, with increasing numbers of patients being found in APAC nations such as China, Thailand, and India. This is likely to remain a major driver for the global diabetic retinopathy market over the forecast period. The increasing geriatric population around the world is also likely to be a major driver for the global diabetic retinopathy market over the forecast period, as geriatrics suffer from weak musculature, including the muscles and tissues around the eyes. 

Competitive Leaderboard:

Leading players in the global diabetic retinopathy market include Abbott Laboratories, Allergan plc, Aurolab, Ampio Pharmaceuticals Inc., Alimera Sciences, Regeneron Pharmaceuticals Inc., and F. Hoffman-La Roche AG. Strategic acquisitions and collaborations are likely to remain promising avenues for players in the global diabetic retinopathy market over the forecast period. Product launches and capacity expansion are also major avenues for players in the global diabetic retinopathy market. 

Segmentation:

The global diabetic retinopathy market is segmented on the basis of type, treatment, end user, and region. 

By type, the global diabetic retinopathy market is segmented into non-proliferative and proliferative. Non-proliferative diabetic retinopathy holds a dominant share in the global diabetic retinopathy market and is likely to remain in the lead over the forecast period. Proliferative diabetic retinopathy is usually the terminal version of diabetic retinopathy. 

By treatment, the global diabetic retinopathy market is segmented into anti-VEGF drugs, laser photocoagulation, vitroretinal surgery, Anti-VEGF drugs are likely to remain one of the dominant segments of the global diabetic retinopathy market over the forecast period. Vitreoretinal surgery is also likely to increase in demand over the forecast period. 

By end user, the global diabetic retinopathy market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment holds the dominant share in the global diabetic retinopathy market. 

Regional Analysis:

The Americas hold the dominant share in the global diabetic retinopathy market and are likely to remain the leading segment over the forecast period. The growing prevalence of diabetes in North America is the major driver for the Americas market for diabetic retinopathy. Increasing awareness about diabetic retinopathy in the region is also another major driver for the global diabetic retinopathy market. 

Europe holds the second largest share in the global diabetic retinopathy market, followed by Asia Pacific. Asia Pacific is likely to exhibit the fastest growth over the forecast period. 

Access Report Details @ https://www.marketresearchfuture.com/reports/diabetic-retinopathy-market-5792 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Venous Blood Collection Devices Market Analysis, COVID-19 Pandemic Impact, Growth, Opportunity Assessment and Trends by Forecast 2027

 Venous blood collection devices are used to collect sample from patients. Venous blood collection devices include needles, holders, collection tubes, and other devices. As per an in-depth research study published by Market Research Future (MRFR), the global venous blood collection devices market is estimated to post a CAGR of 9.3% over the forecast period of 2017-2023. 

Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5761 

Substantial improvements made by medical device manufacturers towards safer blood collection. Advances in safety features and greater emphasis on the prevention of injury and reduction of bloodborne pathogen exposure fuel the growth of the global venous blood collection devices market. Moreover, medical device manufacturers are endeavoring towards product improvement and are diversifying their product portfolios as a growth strategy which also acts as a plus for the growth of the market. Crucial advancements include the introduction of plastic tubes, protective sliding needle shields, automatically retracting lancets, and winged-needle blood collection sets. 

Chronic diseases are spreading at a brisk pace which has exerted massive burden on the healthcare sector. Screening for diseases induces high demand for diagnostic services which, in turn, triggers growth within the global venous blood collection devices market. Other factors which can accelerate the market growth include surging health & wellness awareness among the global populace, the rise in disposable income, and high healthcare expenditure. 

On the flip side, venous blood collection devices are associated with the risk of needlestick injuries, contamination risks which can restrict the market growth. Additionally, pricing pressure on medical device manufacturers and substandard products from local medical device manufacturers can also undermine the growth of the market. 

 

Venous Blood Collection Devices Market Segmentation

The global venous blood collection devices market has been segmented based on type, material, application, and end user.

By type, the global venous blood collection devices market has been segmented into blood collection tubes, needles, microfluidic system, vacuum blood collection system, micro-container tubes, micro-hematocrit tubes, warming devices, and others. Other venous blood collection devices include venous cannula and blood bags. The blood collection tube segment has been further segmented into plasma separation tube, heparin tube, serum separating tube, EDTA tube, and others.

By material, the global blood collection devices market has been segmented into plastic, glass, stainless steel, ceramic, and others.

By application, the global venous blood collection devices market has been segmented into vein blood gas sampling and intraoperative blood salvage. The vein blood gas sampling segment has been further segmented into diagnosis of disease and acid-base status monitoring.

By end user, the global venous blood collection devices market has been segmented into hospitals and clinics, blood donation centers, the point of care, diagnostic centers, and others.

Venous Blood Collection Devices Market Regional Analysis

By region, the global venous blood collection devices market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). 

The Americas is spearheading the global venous blood collection devices market. Rapid adoption of new surgical techniques and instruments within the healthcare sector in the region are substantiating the growth of the market. High demand for screening services coupled with high healthcare expenditure is driving the market growth. Moreover, greater awareness among consumers and favorable reimbursement landscape support the growth of the market. 

Europe ranks second in the global venous blood collection devices market. High-income population and deep healthcare penetration in the region are favoring the growth of the market in Europe.

The expanding healthcare sector in the developing countries such as China and India generate high demand for venous blood collection devices in APAC. The rise in the geriatric population, the prevalence of chronic diseases which require screening services and increased demand for advanced blood sampling techniques are propelling the growth of the APAC venous blood collection devices market.

The MEA market is estimated to expand at a steady pace over the forecast period. Accelerated development of the healthcare sector and awareness programs launched by the government towards safe blood transfusion procedures are triggering growth within the MEA market. 

Competitive Landscape

The key players in the global venous blood collection devices market include SanLI (Myanmar.), KHB (U.S.), Allegro Medical Supplies Inc. (Scrip Products Corporation) (U.S.), Bio-Rad Laboratories, Inc. (U.S), Kabe Labortechnik GmbH (Germany), NIPRO Medical Corporation (Japan), Qiagen NV (Netherlands), Sarstedt AG & Co (U.S.), Fisher Scientific (Thermo Fisher Scientific Inc.) (U.S.), Greiner Bio One International GmbH (Greiner Group) (Austria), Becton, Dickinson and Company (U.S), Terumo Medical Corporation (Japan), Medtronic Plc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Radiometer Medical ApS (Danaher Corporation/ Danrad ApS) (Denmark), Improve Medical Technology Co. Ltd. (U.S.), Sekisui Chemical Co., Ltd. (Japan), Hongyu Medical (China), Narang Medical (India), Vital Diagnostice (ELITech Group) (U.S.), Zhejiang Gongdong Medical Technology Co., Ltd. (China), CDRICH (China), Biosigma (U.S.), Soya Green Tec Co., Ltd. (South Korea), and F.L. Medical (Italy). 

Industry Updates

March 2019- Becton Dickinson & Co., a medical technology company, announced that the US FDA had granted pre-market approval for its new Venovo stent. The new device is ideally suited for the treatment of iliofemoral occlusive disease and specially designed to address the challenges associated with venous lesions. 

Browse Complete Report @ https://www.marketresearchfuture.com/reports/venous-blood-collection-devices-market-5761 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.